The National Institute for Health and Care Excellence (NICE) provides guidance on the appropriate use of GLP-1 receptor agonists within NHS diabetes care pathways
Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with semaglutide tablets Warnings and Precautions Risk of Thyroid C-Cell Tumors: Patients should be further evaluated if serum calcitonin is measured and found to be elevated or thyroid nodules are noted on physical examination or neck imaging Acute Pancreatitis: Acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide tablets
A: Common side effects include nausea, diarrhea, or constipation, which typically improve over time
Latent autoimmunity correlates with humoral responses against SARS-CoV-2 infection and autoimmunity has emerged as a prominent feature of PASC pathology 232
While this situation continues, no lipoedema specific statistics are being collated by healthcare providers to put forward a financial case to support lipoedema funding in the future, so a vicious circle exists
